339 related articles for article (PubMed ID: 21354119)
1. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.
Srivastava SK; Yadav UC; Reddy AB; Saxena A; Tammali R; Shoeb M; Ansari NH; Bhatnagar A; Petrash MJ; Srivastava S; Ramana KV
Chem Biol Interact; 2011 May; 191(1-3):330-8. PubMed ID: 21354119
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibition suppresses airway inflammation.
Yadav UC; Ramana KV; Srivastava SK
Chem Biol Interact; 2011 May; 191(1-3):339-45. PubMed ID: 21334316
[TBL] [Abstract][Full Text] [Related]
3. A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.
Pandey S; Srivastava SK; Ramana KV
Expert Opin Investig Drugs; 2012 Mar; 21(3):329-39. PubMed ID: 22283786
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.
Ramana KV; Fadl AA; Tammali R; Reddy AB; Chopra AK; Srivastava SK
J Biol Chem; 2006 Nov; 281(44):33019-29. PubMed ID: 16956889
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice.
Yadav UC; Ramana KV; Aguilera-Aguirre L; Boldogh I; Boulares HA; Srivastava SK
PLoS One; 2009 Aug; 4(8):e6535. PubMed ID: 19657391
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase: a novel therapeutic target for inflammatory pathologies.
Ramana KV; Srivastava SK
Int J Biochem Cell Biol; 2010 Jan; 42(1):17-20. PubMed ID: 19778627
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
9. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
[TBL] [Abstract][Full Text] [Related]
11. Targeting aldose reductase for the treatment of cancer.
Tammali R; Srivastava SK; Ramana KV
Curr Cancer Drug Targets; 2011 Jun; 11(5):560-71. PubMed ID: 21486217
[TBL] [Abstract][Full Text] [Related]
12. Progresses in the pursuit of aldose reductase inhibitors: the structure-based lead optimization step.
Ramunno A; Cosconati S; Sartini S; Maglio V; Angiuoli S; La Pietra V; Di Maro S; Giustiniano M; La Motta C; Da Settimo F; Marinelli L; Novellino E
Eur J Med Chem; 2012 May; 51():216-26. PubMed ID: 22436396
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.
Yadav UC; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4634-42. PubMed ID: 17898287
[TBL] [Abstract][Full Text] [Related]
14. Aldose Reductase Mediates NLRP3 Inflammasome-Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice.
Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
Endocrinology; 2017 Oct; 158(10):3661-3675. PubMed ID: 28938395
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.
Ramana KV; Reddy AB; Tammali R; Srivastava SK
Free Radic Biol Med; 2007 Apr; 42(8):1290-302. PubMed ID: 17382209
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition.
Ramana KV; Willis MS; White MD; Horton JW; DiMaio JM; Srivastava D; Bhatnagar A; Srivastava SK
Circulation; 2006 Oct; 114(17):1838-46. PubMed ID: 17030682
[TBL] [Abstract][Full Text] [Related]
18. ALDOSE REDUCTASE: New Insights for an Old Enzyme.
Ramana KV
Biomol Concepts; 2011 Apr; 2(1-2):103-114. PubMed ID: 21547010
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth.
Ramana KV; Bhatnagar A; Srivastava S; Yadav UC; Awasthi S; Awasthi YC; Srivastava SK
J Biol Chem; 2006 Jun; 281(26):17652-60. PubMed ID: 16648138
[TBL] [Abstract][Full Text] [Related]
20. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
